ReviewFrontiers in oncology2026
Artificial intelligence-assisted radiotherapy for pelvic and abdominal malignancies: assessing feasibility in the context of Africa-specific risks.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer care in Africa remains severely limited, with pelvic and abdominal malignancies contributing substantially to the disease burden. Radiotherapy is essential but constrained by infrastructure deficits, workforce shortages, and systemic inequities. Artificial intelligence (AI) may help strengthen radiotherapy through automation and improved workflow efficiency. This narrative review summarises current evidence on AI assisted radiotherapy for pelvic and abdominal cancers in Africa, highlighting feasibility, and regional specific implementation risks. The review shows that AI tools for auto-contouring, treatment planning support, quality assurance, and workflow optimisation can improve efficiency and ease workload when implemented within appropriate clinical and governance frameworks. Their clinical impact in African radiotherapy, however, is constrained by limited digital infrastructure, workforce shortages, weak data governance, regulatory gaps, and poor model generalisability. Additional risks including data bias from non-African training datasets, and fragile IT systems underscore the need for cautious deployment. A feasibility-first, phased adoption strategy centred on hybrid AI-human workflows, regional model validation, workforce upskilling, and policy-led governance offers a safe and practical route for integrating AI into African radiotherapy. When integrated within resilient systems and guided by risk-aware strategies, AI has the potential to act as a capacity multiplier rather than a substitute, offering a more equitable access to high quality radiotherapy across Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.